CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs

Medicare and Medicaid have faced persistent double-digit increases in the prices of insulin products, as well as notable jumps in the cost of other well-established medicines dating to the 1990s.Medscape Medical News
Source: Medscape Business of Medicine Headlines - Category: Pharmaceuticals Tags: Family Medicine/Primary Care News Source Type: news